Recalls / Firms / Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc.
10 FDA drug recalls on record.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2019-11-22 | Class II | Ranitidine Tablets, USP 150 mg a).60-count bottles (NDC 65162-253-06) , b).100-count bott | Ongoing |
| 2019-11-22 | Class II | Ranitidine | Ongoing |
| 2019-11-22 | Class II | Ranitidine | Ongoing |
| 2019-11-22 | Class II | Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz. (473 mL), NDC 65162-664-90. | Ongoing |
| 2019-11-22 | Class II | Ranitidine Tablets, USP 300 mg - a).30-count bottles (NDC 65162-254-30), b).100-count bott | Ongoing |
| 2019-10-16 | Class III | Isotretinoin | Terminated |
| 2019-09-24 | Class III | Benazepril Hydrochloride | Terminated |
| 2019-07-18 | Class III | Methylergonovine Maleate USP 0.2 mg Tablets a) 12 count (NDC 69238-1605-02) and b) 28 cou | Terminated |
| 2017-09-25 | Class III | Esterified Estrogens & Methyltestosterone Tablets, USP 0.625 mg/1.25 mg, 100-count bottle | Terminated |
| 2017-09-25 | Class III | Esterified Estrogens & Methyltestosterone Tablets, USP 1.25 mg/2.5 mg, 100-count bottles, | Terminated |